CSVZX | VIVAX | CSVZX / VIVAX | |
Total Expense Ratio | 0.55 | 0.17 | 324% |
Annual Report Gross Expense Ratio | 0.83 | 0.17 | 488% |
Fund Existence | 15 years | 33 years | - |
Gain YTD | 14.257 | 7.845 | 182% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.49B | 203B | 1% |
Annual Yield % from dividends | 1.65 | 1.99 | 83% |
Returns for 1 year | 13.16 | 7.74 | 170% |
Returns for 3 years | 42.78 | 36.63 | 117% |
Returns for 5 years | 70.16 | 70.18 | 100% |
Returns for 10 years | 102.50 | 131.64 | 78% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SSEAX | 13.27 | 0.11 | +0.84% |
SEI Screened World Equity Ex-US A (SIIT) | |||
NMIEX | 13.47 | 0.07 | +0.52% |
Northern Active M International Equity | |||
ISTNX | 88.82 | N/A | N/A |
Macquarie Science and Technology R6 | |||
NEQCX | 12.41 | N/A | N/A |
Neuberger Berman U.S. Equity Impact C | |||
MUSBX | 36.94 | -0.11 | -0.30% |
MFS Blended Research Core Equity B |